Lack of Clinical Evidence Leaves Questions about Orthobiologic Development and Promotion
by Scott Burder, M.D., Ph.D. | Dec 2019
In the race to capitalize on patient-driven interest in stem cells, biologic and regenerative solutions, there has been an explosion of offerings that lack scientific controls, validity and meaningful evidence. Companies now have until November 2020 to comply with new FDA regulations. Enforcement, t ... Read more »